BSE - Delayed Quote • INR
Godavari Drugs Limited (GODAVARI.BO)
At close: April 26 at 3:29 PM GMT+5:30
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,554,415.00
1,596,248.00
1,611,062.00
1,226,702.00
Cost of Revenue
1,219,686.00
1,280,577.00
1,304,555.00
965,882.00
Gross Profit
334,729.00
315,671.00
306,507.00
260,820.00
Operating Expense
219,813.00
216,527.00
208,126.00
174,648.00
Operating Income
114,916.00
99,144.00
98,381.00
86,172.00
Net Non Operating Interest Income Expense
-45,836.00
-37,988.00
-27,389.00
-32,406.00
Pretax Income
56,773.00
49,347.00
70,206.00
57,064.00
Tax Provision
14,589.00
11,489.00
17,753.00
15,783.00
Net Income Common Stockholders
42,184.00
37,858.00
52,453.00
41,281.00
Diluted NI Available to Com Stockholders
42,184.00
37,858.00
52,453.00
41,281.00
Basic EPS
5.60
5.03
6.97
5.48
Diluted EPS
5.60
5.03
6.97
5.48
Basic Average Shares
7,533.18
7,526.44
7,525.54
7,533.03
Diluted Average Shares
7,533.18
7,526.44
7,525.54
7,533.03
Rent Expense Supplemental
480.00
1,187.00
1,088.00
999.00
Total Expenses
1,439,499.00
1,497,104.00
1,512,681.00
1,140,530.00
Net Income from Continuing & Discontinued Operation
42,184.00
37,858.00
52,453.00
41,281.00
Normalized Income
40,911.93
36,097.32
52,453.00
41,281.00
Interest Income
692.31
1,285.00
1,103.00
803.00
Interest Expense
36,506.00
28,658.00
16,795.00
21,391.00
Net Interest Income
-45,836.00
-37,988.00
-27,389.00
-32,406.00
EBIT
93,279.00
78,005.00
87,001.00
78,455.00
EBITDA
112,867.00
97,440.00
103,965.00
90,682.00
Reconciled Cost of Revenue
1,219,686.00
1,280,577.00
1,304,555.00
965,882.00
Reconciled Depreciation
19,588.00
19,435.00
16,964.00
12,227.00
Net Income from Continuing Operation Net Minority Interest
42,184.00
37,858.00
52,453.00
41,281.00
Total Unusual Items Excluding Goodwill
1,712.00
2,295.00
--
--
Total Unusual Items
1,712.00
2,295.00
--
--
Normalized EBITDA
111,155.00
95,145.00
103,965.00
90,682.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
439.93
534.32
--
--
3/31/2021 - 1/25/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade